GlassScriptPhysician profile
Gregory Kahler Low
NPI 1194269944
$6,407.75
in general payments reported to CMS, 2019-2025
17 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $5,072 · 2023: $565 · 2024: $370 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,970.91 | 2021-2024 | Da Vinci Surgical System |
| Takeda Pharmaceuticals U.S.A., INC. | $292.45 | 2022-2025 | Gattex |
| Kerecis Limited | $191.00 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Medtronic, INC. | $170.90 | 2022-2024 | Interstim, Gia |
| La Jolla Pharmaceutical Company | $134.62 | 2021-2024 | Xerava |
| Innovation Technologies INC | $115.37 | 2021-2023 | Irrisept |
| Ethicon US, LLC | $112.69 | 2022-2025 | Vistaseal, Echelon; Endopath, Echelon Circular |
| Ambu INC. | $65.60 | 2022-2023 | |
| Dilon Technologies, INC. | $62.50 | 2025 | Hemoblast Bellows |
| Abbvie INC. | $55.57 | 2024 | |
| Integra Lifesciences Corporation | $54.58 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Olympus America INC. | $53.29 | 2021-2023 | Olympus |
| Sanara Medtech INC. | $48.54 | 2022-2023 | Celleraterx |
| Thd America, INC. | $22.38 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $21.66 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $19.47 | 2025 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $16.22 | 2024 | Iovera, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Low listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.